2020-08-20T07:44:53-05:00 2019-12-31 221478099 COHNREZNICK LLP 4 BECKER FARM ROAD ROSELAND NJ 07068 990 2019-01-01 112329960 ODA PRIMARY HEALTH CARE NETWORK INC ODAP 7182604600 14-16 HEYWARD STREET BROOKLYN NY 112497823 ROSE ROSENFELD CFO 7182604600 2020-08-17 1 LORI ROTHE YOKOBOSKY CPA P01273422 9732283500 2020-08-17 209.59.242.22 2020-08-17 17:28:46 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 6C9B1A35775087DBDB8A6D25ECA509C7F6C27838 2019 2020-09-22 18:59:49Z JOSEPH DEUTSCH 14-16 HEYWARD STREET BROOKLYN NY 112497823 62753575 0 X WWW.ODAHEALTH.ORG X 1974 NY TO PROVIDE QUALITY PRIMARY AND SPECIALTY CARE TO A LARGE MEDICALLY UNDERSERVED POPULATION IN THE WILLIAMSBURG SECTION OF BROOKLYN 13 13 451 0 0 0 9704960 9276471 50674084 51335298 2202 -3764 2332160 2141421 62713406 62749426 0 0 0 0 41076681 43596913 0 0 0 23840133 21323957 64916814 64920870 -2203408 -2171444 48582785 42757967 28835884 25182510 19746901 17575457 X IMPROVE THE HEALTH STATUS, IN ALL LIFE CYCLES, OF THE MEDICALLY UNDER-SERVED INDIVIDUALS OF THE SOUTH WILLIAMSBURG COMMUNITY BY PROVIDING AFFORDABLE, COMPREHENSIVE AND HIGH QUALITY PRIMARY AND SPECIALTY MEDICAL CARE SERVICES, WITH ASSURANCES THAT NO UNINSURED INDIVIDUAL IS TO BE DENIED CARE IF THEY ARE UNABLE TO PAY. 0 0 54388456 53476719 THE CENTER PROVIDES A BROAD RANGE OF SERVICES TO A LARGELY MEDICALLY UNDERSERVED POPULATION. DURING 2019, THE CENTER HAD 289,687 PATIENT VISITS. 54388456 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 66 0 1 451 0 0 0 0 0 0 0 0 0 0 0 0 0 X 13 13 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 NY X ROSE ROSENFELD 7182604600 14-16 HEYWARD ST BROOKLYN NY 11249 AARON ENGEL BOARD MEMBER 1.00 X 0 0 0 ABRAHAM FRIEDLANDER BOARD MEMBER 1.00 X 0 0 0 AKIVA KOBRE VICE PRESIDENT 1.00 X X 0 0 0 BELA GLUCK BOARD MEMBER 1.00 X 0 0 0 CHAVIE LEIBERMAN BOARD MEMBER 1.00 X 0 0 0 DAVID HURWITZ SECRETARY/TREASURER 1.00 X X 0 0 0 DAWN JIMENEZ BOARD MEMBER 1.00 X 0 0 0 HERSCHEL BERKOWITZ BOARD MEMBER 1.00 X 0 0 0 ISSAC KATZ BOARD MEMBER 1.00 X 0 0 0 LOUIS KESTENBAUM PRESIDENT 1.00 X X 0 0 0 MOSHE FRIEDMAN BOARD MEMBER 1.00 X 0 0 0 NAFTALI AUSCH BOARD MEMBER 1.00 X 0 0 0 NAFTALI HOROWITZ BOARD MEMBER 1.00 X 0 0 0 JOEL KESTENBAUM COO 40.00 X 333472 0 42732 JOSEPH DEUTSCH CEO 40.00 X 612896 0 42308 ROSE ROSENFELD CFO 40.00 X 357620 0 42584 AFSHIN SHAHKOOHI PEDIATRICIAN 52.00 X 977204 0 48031 CHANDRAKANT M PATEL PEDIATRICIAN 46.00 X 680816 0 305 JIMMY SITT PEDIATRICIAN 62.00 X 598484 0 42732 PHILIP ZAVELOFF ENDODONTIC DENTIST 43.00 X 501907 0 42732 KYI WIN YU PHYSICIAN FAMILY PRACTICE 95.00 X 716976 0 32052 4779375 0 293476 103 0 1 0 ELITE MEDICAL SOLUTIONS 12 HEYWARD STREET 315 BROOKLYN NY 11249 BILLING SERVICES 1572000 PRESTIGE BUILDING SOLUTIONS 4403 15TH AVE BROOKLYN NY 11219 MAINTENANCE SERVICE 1109352 BIG IDEA TECHNOLOGY LLC 450 SEVENTH AVE SUITE 1003 NEW YORK NY 10123 IT SERVICES 368523 GARFUNKEL WILD PC 111 GREAT NECK ROAD GREAT NECK NY 11021 LEGAL SERVICES 342578 COHN REZNICK LLP 1301 AVENUE OF THE AMERICAS NEW YORK NY 10019 AUDIT AND TAX SERVICES 220006 14 5892889 3383582 1020324 9276471 MEDICAID MANAGED CARE 621400 21050874 21050874 MEDICAID MANAGED CARE WRAP AROUND 621400 14247013 14247013 MEDICAID 621400 6202260 6202260 NYS UNCOMPENSATED CARE 621400 3791803 3791803 OTHER THRID PARTY 621400 3142264 3142264 2901084 2901084 51335298 385 385 4149 -4149 -4149 -4149 340B PHARMACY 900099 2141421 2141421 2141421 62749426 53476719 0 -3764 1432612 1255206 177406 36058532 31593247 4465285 3675107 3489117 185990 2430662 1860548 570114 443950 443950 262099 262099 60000 60000 4682168 2440428 2241740 1309723 1147266 162457 2172807 1820961 351846 776601 769378 7223 1884 1866 18 1601193 1341909 259284 2360324 1978112 382212 186894 160251 26643 PHARMACEUTICAL SUPPLIES 2201710 1940021 261689 MEDICAL SUPPLIES 1899924 1899924 REPAIR AND MAINTENANCE 1892651 1401157 491494 PUBLIC EDUCATION & RECR 707286 593442 113844 764743 695623 69120 64920870 54388456 10532414 0 254931 1395103 10720513 1808069 987612 8283403 6619959 212513 481153 41468118 13436402 25703270 28031716 2990500 2863500 417655 570855 48582785 42757967 5824556 7625274 16759444 16619985 6251884 937251 28835884 25182510 X 19746901 17575457 19746901 17575457 48582785 42757967 -2171444 0 X X 0 1 X 1 1 1 X 3053992 4204815 4756198 9704960 9276471 30996436 3053992 4204815 4756198 9704960 9276471 30996436 30996436 838 1140 610 2202 385 5175 16902 49747 1258968 2332160 2141421 5799198 36800809 233948177 0.84230 0.85970 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2016 AMOUNT: $ 23,619. 2018 AMOUNT: $ 16,985. 340B PHARMACY - 2015 AMOUNT: $ 16,902. 2016 AMOUNT: $ 26,128. 2017 AMOUNT: $ 1,258,968. 2018 AMOUNT: $ 2,315,175. 2019 AMOUNT: $ 2,141,421. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 1 60000 60000 0 PART II-B, LINE 1: ODA ENGAGED A PROFESSIONAL LOBBYIST TO MAINTAIN AND ENHANCE ITS FACILITY LOCATED IN THE WILLIAMSBURG SECTION OF BROOKLYN. 100000 100000 16266917 5021742 11245175 19040139 5110097 13930042 4869356 2602749 2266607 1191706 701814 489892 28031716 DEFERRED RENT 937251 937251 X 62753190 0 62753190 -3764 -3764 62749426 64924634 3764 3764 64920870 0 64920870 PART X, LINE 2: THE NETWORK HAS NO UNRECOGNIZED TAX BENEFITS AT DECEMBER 31, 2019. THE NETWORK'S FEDERAL AND STATE INCOME TAX RETURNS PRIOR TO FISCAL YEAR 2015 ARE CLOSED AND MANAGEMENT CONTINUALLY EVALUATES EXPIRING STATUTES OF LIMITATIONS, AUDITS, PROPOSED SETTLEMENTS, CHANGES IN TAX LAW AND NEW AUTHORITATIVE RULINGS. THE NETWORK RECOGNIZES INTEREST AND PENALTIES ASSOCIATED WITH TAX MATTERS AS OPERATING EXPENSES AND INCLUDES ACCRUED INTEREST AND PENALTIES WITH ACCRUED EXPENSES IN THE STATEMENT OF FINANCIAL POSITION. PART XI, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL OF FIXED ASSETS -4,149. INTEREST 385. PART XII, LINE 2D - OTHER ADJUSTMENTS: LOSS ON DISPOSAL OF FIXED ASSETS 4,149. INTEREST -385. PART XII, LINE 4B - OTHER ADJUSTMENTS: BAD DEBT EXPENSE MEDICAID RECOUPMENT X X X X X 0 0 0 0 0 0 0 1 0 JOEL KESTENBAUM COO 243472 0 90000 0 0 0 0 0 42732 0 376204 0 0 0 JOSEPH DEUTSCH CEO 612896 0 0 0 0 0 0 0 42308 0 655204 0 0 0 ROSE ROSENFELD CFO 357620 0 0 0 0 0 0 0 42584 0 400204 0 0 0 AFSHIN SHAHKOOHI PEDIATRICIAN 900007 0 77197 0 0 0 0 0 48031 0 1025235 0 0 0 CHANDRAKANT M PATEL PEDIATRICIAN 584066 0 96750 0 0 0 0 0 305 0 681121 0 0 0 JIMMY SITT PEDIATRICIAN 401745 0 196739 0 0 0 0 0 42732 0 641216 0 0 0 PHILIP ZAVELOFF ENDODONTIC DENTIST 501907 0 0 0 0 0 0 0 42732 0 544639 0 0 0 KYI WIN YU PHYSICIAN FAMILY PRACTICE 716976 0 0 0 0 0 0 0 32052 0 749028 0 0 0 PART I, LINE 7 INCLUDED IN COLUMN B(II) OF PART II ARE BONUS AND INCENTIVE AMOUNTS. THESE AMOUNTS WERE APPROVED BY THE BOARD, AND INCLUDED ON THE INDIVIDUALS 2019 W-2. X 1 1020324 FMV 0 0 0 PART I, COLUMN (B): AMOUNTS IN PART I, COLUMN B REPRESENT THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION A, LINE 2 LOUIS KESTENBAUM, ROSE ROSENFELD AND JOEL KESTENBAUM HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE CFO/CEO AND BOARD REVIEW THE 990 BEFORE IT IS FILED. IN ADDITION THE RETURN IS REVIEWED BY THE FINANCE COMMITTEE PRIOR TO THE FILING OF THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY EACH BOARD MEMBER ARE REQUIRED TO SIGN CONFLICT OF INTEREST FORM DISLOSURE. THE ORGANIZATION REGULARLY AND CONSISTENTLY MONITORS ITS CONFLICTS OF INTEREST POLICY. BOARD MEMBERS WITH A CONFLICT OF INTEREST ARE PROHIBITED FROM PARTICIPATING IN DELIBERATION AND DECISIONS IN A CONFLICTED TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15A IN DETERMINING COMPENSATION FOR THE CEO, CFO AND COO, AS WELL AS THE HIGHLY COMPENSATED PHYSICIAN EMPLOYEES, ODA USES AN OUTSIDE INDEPENDENT CONSULTANT TO PERFORM A COMPENSATION STUDY WHICH CONSIDERS LIKE INDIVIDUALS IN THE MARKET IN DETERMINING THE COMPENSATION RATES. THE CHAIR AND FINANCE COMMITTEE REVIEW AND APPROVE THE COMPENSATION FOR THESE INDIVIDUALS IN RELIANCE ON THE COMPENSATION STUDY. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THE BOARD OF DIRECTORS ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF INDEPENDENT AUDITORS.